Second-line endocrine treatment of advanced breast cancer--a randomized cross-over study of medroxy-progesterone acetate and aminoglutethimide.
Hultborn
R
R
Department of Oncology, Sahlgrenska Hospital, Göteborg, Sweden.
Johansson-Terje
I
I
Bergh
J
J
Glas
U
U
Hallsten
L
L
Hatschek
T
T
Holmberg
E
E
Ideström
K
K
Norberg
B
B
Ranstam
J
J
Söderberg
M
M
Wallgren
U B
UB
D000616:Aminoglutethimide / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D018592:Cross-Over Studies; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D045167:Progesterone Congeners / Q000627:therapeutic use*; D011788:Quality of Life
D018931:Antineoplastic Agents, Hormonal; D045167:Progesterone Congeners; D000616:Aminoglutethimide; D008525:Medroxyprogesterone